Clinical Trial Update: Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion and posting of results for a Phase 1/2 study of Stellate Ganglion Block to treat COVID-19-induced olfactory dy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anosmia
• Hyposmia
• Olfactory Dysfunction
• Parosmia

Snippet

Sponsor: Washington University School of Medicine | Conditions: Anosmia, Hyposmia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-11-07